EZH2 promotes neoplastic transformation through VAV interaction-dependent extranuclear mechanisms
Authors:
- 2 October 2017
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 37 (4) , 461-477
Abstract
Recently, we reported that the histone methyltransferase, EZH2, controls leukocyte migration through interaction with the cytoskeleton remodeling effector, VAV, and direct methylation of the cytoskeletal regulatory protein, Talin. However, it is unclear whether this extranuclear, epigenetic-independent function of EZH2 has a profound impact on the initiation of cellular transformation and metastasis. Here, we show that EZH2 increases Talin1 methylation and cleavage, thereby enhancing adhesion turnover and promoting accelerated tumorigenesis. This transforming capacity is abolished by targeted disruption of EZH2 interaction with VAV. Furthermore, our studies demonstrate that EZH2 in the cytoplasm is closely associated with cancer stem cell properties, and that overexpression of EZH2, a mutant EZH2 lacking its nuclear localization signal (EZH2ΔNLS), or a methyl-mimicking Talin1 mutant substantially promotes JAK2-dependent STAT3 activation and cellular transformation. Taken together, our results suggest a critical role for the VAV interaction-dependent, extranuclear action of EZH2 in neoplastic transformation.Keywords
This publication has 81 references indexed in Scilit:
- EZH2 Generates a Methyl Degron that Is Recognized by the DCAF1/DDB1/CUL4 E3 Ubiquitin Ligase ComplexMolecular Cell, 2012
- Genetic inactivation of the polycomb repressive complex 2 in T cell acute lymphoblastic leukemiaNature Medicine, 2012
- The genetic basis of early T-cell precursor acute lymphoblastic leukaemiaNature, 2012
- EZH2 Promotes Expansion of Breast Tumor Initiating Cells through Activation of RAF1-β-Catenin SignalingCancer Cell, 2011
- Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center originNature Genetics, 2010
- Mir-214-Dependent Regulation of the Polycomb Protein Ezh2 in Skeletal Muscle and Embryonic Stem CellsMolecular Cell, 2009
- Ezh2 Orchestrates Gene Expression for the Stepwise Differentiation of Tissue-Specific Stem CellsCell, 2009
- Control of Developmental Regulators by Polycomb in Human Embryonic Stem CellsCell, 2006
- The STATs of cancer — new molecular targets come of ageNature Reviews Cancer, 2004
- FAK–Src signalling through paxillin, ERK and MLCK regulates adhesion disassemblyNature Cell Biology, 2004